Ignite Creation Date:
2025-12-24 @ 5:28 PM
Ignite Modification Date:
2025-12-29 @ 10:48 PM
Study NCT ID:
NCT04234568
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-12-22
First Post:
2020-01-17
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Testing the Addition of an Anti-cancer Drug, Triapine, to the Usual Radiation-Based Treatment (Lutetium Lu 177 Dotatate) for Neuroendocrine Tumors
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-07-20
Start Date Type:
ACTUAL
Primary Completion Date:
2024-09-17
Primary Completion Date Type:
ACTUAL
Completion Date:
2026-03-14
Completion Date Type:
ESTIMATED
First Submit Date:
2020-01-17
First Submit QC Date:
None
Study First Post Date:
2020-01-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-10-01
Results First Submit QC Date:
None
Results First Post Date:
2025-11-03
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2025-03-18
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2025-12-04
Last Update Post Date:
2025-12-22
Last Update Post Date Type:
ESTIMATED